Acute Pharyngitis Market to Reach $4.24B by 2030 at 8% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Acute Pharyngitis Market From 2026 To 2030?

The acute pharyngitis market has demonstrated significant expansion in recent years. It is anticipated to increase from $2.89 billion in 2025 to $3.13 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. This historical growth can be ascribed to the substantial occurrence of viral and bacterial pharyngitis, inadequate treatment awareness, the expansion of healthcare facilities, an increase in outpatient consultations, and the enhanced accessibility of pharmaceutical treatments.

The acute pharyngitis market is set for significant expansion in the upcoming years, projected to reach $4.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This growth throughout the forecast period is fueled by the development of new antivirals and antibiotics, a rise in telemedicine adoption, the expansion of online pharmacy platforms, increasing public awareness of herbal and alternative remedies, and the wider availability of homecare and specialty care services. Prominent trends expected in this timeframe include a greater utilization of antibiotics and antivirals for acute pharyngitis, an increased uptake of over-the-counter medications, a rising preference for herbal and alternative treatments, the broadening of hospital and homecare treatment options, and a focus on anti-inflammatory and corticosteroid therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/acute-pharyngitis-global-market-report

Which Important Drivers Are Guiding The Acute Pharyngitis Market Growth?

An increase in influenza cases is anticipated to drive the expansion of the acute pharyngitis market moving forward. Influenza is caused by infection with influenza viruses, which spread through respiratory droplets from coughing, sneezing, or contact with contaminated surfaces. The rising prevalence of influenza is attributed to factors such as seasonal variations, low vaccination rates, increased human movement, viral mutations, and weakened immunity in certain populations. Acute pharyngitis treatment assists influenza patients by reducing throat inflammation and pain, minimizing discomfort during swallowing, preventing secondary bacterial infections, and supporting overall recovery. When combined with antiviral medications, adequate hydration, and rest, this treatment enhances the body’s capacity to combat the influenza virus more effectively. For instance, according to the Centers for Disease Control and Prevention, a US-based government agency, as of February 2025, the percentage of clinical lab tests positive for influenza reached 31.6%, an increase from 29.4% the previous week and 18.6% at the start of the year. Consequently, the growing prevalence of influenza is propelling the growth of the acute pharyngitis market.

What Segment Categories Shape The Acute Pharyngitis Market Segment Landscape?

The acute pharyngitis market covered in this report is segmented –

1) By Treatment: Antibiotics, Antivirals, Over-the-Counter (OTC) Medications, Corticosteroids And Anti-inflammatory Drugs

2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

3) By End-User: Hospitals, Homecare, Speciality Centres, Other End Users

Subsegments:

1) By Antibiotics: Penicillins, Cephalosporins, Macrolides

2) By Antivirals: Neuraminidase Inhibitors, Nucleoside Analogs

3) By Over-the-Counter (OTC) Medications: Analgesics, Throat Lozenges, Cough Syrups

4) By Corticosteroids And Anti-inflammatory Drugs: Glucocorticoids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

What Trends Are Influencing The Evolution Of The Acute Pharyngitis Market?

Leading companies in the acute pharyngitis market are focusing on developing advanced solutions, such as multiplex syndromic POC testing, to enhance diagnostic speed, improve accuracy, and support pathogen-specific treatment decisions. This multiplex POC testing refers to a technological approach that can detect multiple pathogens from a single sample in a short time, enabling clinicians to differentiate between viral and bacterial infections and reduce unnecessary antibiotic use. For instance, in June 2024, bioMérieux, a France-based medical equipment manufacturer, received FDA Special 510(k) clearance and a CLIA waiver for its BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel Mini. This panel identifies common viral causes of sore throat as well as Group A Streptococcus from a single throat or nasopharyngeal swab in approximately 15 minutes. The test operates on the BIOFIRE SPOTFIRE platform, allowing clinicians to choose a small or larger multiplex respiratory panel depending on their need and setting. The Mini panel demonstrates strong sensitivity for four respiratory viruses, including rhinovirus and influenza, and for Streptococcus A, thereby assisting clinicians in making rapid, targeted treatment decisions.

Who Are The Companies Operating Across The Acute Pharyngitis Market Value Chain?

Major companies operating in the acute pharyngitis market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, F. Hoffmann La Roche AG, Abbott Laboratories, Bayer AG, Eli Lilly and Company, Bristol Myers Squibb Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Hikma Pharmaceuticals PLC, Lupin Limited, Alkem Laboratories Ltd., Cipla Limited, Sun Pharmaceutical Industries Limited

Get The Full Acute Pharyngitis Market Report:

https://www.thebusinessresearchcompany.com/report/acute-pharyngitis-global-market-report

Which Region Holds The Highest Market Share In The Acute Pharyngitis Market?

North America was the largest region in the acute pharyngitis market in 2025. The regions covered in the acute pharyngitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Acute Pharyngitis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/acute-pharyngitis-global-market-report

Browse Through More Reports Similar to the Global Acute Pharyngitis Market 2026, By The Business Research Company

Acute Bacterial Skin And Skin Structure Infections Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-bacterial-skin-and-skin-structure-infections-global-market-report

Severe Acute Respiratory Syndrome Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/severe-acute-respiratory-syndrome-treatment-global-market-report

Esophageal Dysphagia Market Report 2026

https://www.thebusinessresearchcompany.com/report/esophageal-dysphagia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795